best performing mid cap stocks in 2017-2018

CareDx (CDNA) had the highest return between 2017 and 2018 by a mid-cap US stock, returning 766.9%.

ASSETYEARS% RETURN
CareDx (CDNA)
2017-2018
766.9%
Arrowhead Pharmaceuticals (ARWR)
2017-2018
696.15%
Kinetik (KNTK)
2017-2018
692.82%
Madrigal Pharmaceuticals (MDGL)
2017-2018
653.98%
Viking Therapeutics (VKTX)
2017-2018
537.5%
Vericel Corp Ord (VCEL)
2017-2018
470.49%
Enphase Energy (ENPH)
2017-2018
363.73%
Trade Desk (TTD)
2017-2018
313.76%
Ringcentral (RNG)
2017-2018
292.57%
RH (RH)
2017-2018
289.03%
Crocs (CROX)
2017-2018
273.28%
Option Care Health (OPCH)
2017-2018
227.52%
Aurinia Pharmaceuticals (AUPH)
2017-2018
218.69%
Aya Gold & Silver Inc Common Shares (AYA)
2017-2018
218.18%
Freshpet (FRPT)
2017-2018
215.29%
PTC Therapeutics (PTCT)
2017-2018
210.31%
Autohome (ATHM)
2017-2018
210.07%
Five9 (FIVN)
2017-2018
205.09%
Novanta (NOVT)
2017-2018
196.47%
Warrior Met Coal (HCC)
2017-2018
185.15%
People (PPLI)
2017-2018
179.88%
Planet Fitness (PLNT)
2017-2018
163.36%
Workiva (WK)
2017-2018
161.02%
Match (MTCH)
2017-2018
160.81%
Integer (ITGR)
2017-2018
155.48%
Mid-cap stocks are treated as having a market cap between $2B and $10B.